Cargando…

Fibrinogen gamma gene rs2066865 and risk of cancer-related venous thromboembolism

Venous thromboembolism (VTE) is a frequent complication in patients with cancer. Homozygous carriers of the fibrinogen gamma gene (FGG) rs2066865 have a moderately increased risk of VTE, but the effect of the FGG variant in cancer is unknown. We aimed to investigate the effect of the FGG variant and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paulsen, Benedikte, Skille, Hanne, Smith, Erin N., Hveem, Kristian, Gabrielsen, Maiken E., Brækkan, Sigrid K., Rosendaal, Frits R., Frazer, Kelly A., Gran, Olga V., Hansen, John-Bjarne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ferrata Storti Foundation 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327659/ https://www.ncbi.nlm.nih.gov/pubmed/31582554 http://dx.doi.org/10.3324/haematol.2019.224279

Ejemplares similares

Association of smoking and cancer with the risk of venous thromboembolism: the Scandinavian Thrombosis and Cancer cohort
por: Paulsen, Benedikte, et al.
Publicado: (2021)

Polymorphism rs2066865 in the Fibrinogen Gamma Chain (FGG) Gene Increases Plasma Fibrinogen Concentration and Is Associated with an Increased Microvascular Thrombosis Rate
por: Drizlionoka, Karina, et al.
Publicado: (2019)

Long-Term Incidence of Venous Thromboembolism in Cancer: The Scandinavian Thrombosis and Cancer Cohort
por: Gade, Inger Lise, et al.
Publicado: (2018)

Survival after cancer-related venous thrombosis: the Scandinavian Thrombosis and Cancer Study
por: Crobach, Monique J. T., et al.
Publicado: (2023)

Role of microRNAs in Venous Thromboembolism
por: Morelli, Vânia M., et al.
Publicado: (2020)

Weight Change and Risk of Venous Thromboembolism: The Tromsø Study
por: Horvei, Lars Daae, et al.
Publicado: (2016)

Plasma procoagulant phospholipid clotting time and venous thromboembolism risk
por: Ramberg, Cathrine, et al.
Publicado: (2021)

Dietary intake of marine n‐3 polyunsaturated fatty acids and future risk of venous thromboembolism
por: Isaksen, Trond, et al.
Publicado: (2018)

D-Dimer Measured at Diagnosis of Venous Thromboembolism is Associated with Risk of Major Bleeding
por: Johnsen, Håkon S., et al.
Publicado: (2019)

Hand grip strength in venous thromboembolism: risk of recurrence and mortality
por: Leknessund, Oda G.R., et al.
Publicado: (2023)

Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism
por: Frischmuth, Tobias, et al.
Publicado: (2022)

Platelet Count Measured Prior to Cancer Development Is a Risk Factor for Future Symptomatic Venous Thromboembolism: The Tromsø Study
por: Jensvoll, Hilde, et al.
Publicado: (2014)

White Blood Cell Count Measured Prior to Cancer Development Is Associated with Future Risk of Venous Thromboembolism – The Tromsø Study
por: Blix, Kristine, et al.
Publicado: (2013)

Risk factors and predictors for venous thromboembolism in people with ischemic stroke: A systematic review
por: Tøndel, Birgitte G., et al.
Publicado: (2022)

Surgery As a Trigger for Incident Venous Thromboembolism: Results from a Population-Based Case-Crossover Study
por: Meknas, Dana, et al.
Publicado: (2023)

The role of dyslipidemia and statins in venous thromboembolism
por: Ray, Joel G, et al.
Publicado: (2001)

The Interaction Between Venous Thromboembolism and Socioeconomic Status on the Risk of Disability Pension
por: Jørgensen, Helle, et al.
Publicado: (2022)

Hand grip strength and risk of incident venous thromboembolism: The Tromsø study
por: Leknessund, Oda G. R., et al.
Publicado: (2022)

Impact of respiratory symptoms and oxygen saturation on the risk of incident venous thromboembolism—the Tromsø study
por: Børvik, Trond, et al.
Publicado: (2020)

Acute infection as a trigger for incident venous thromboembolism: Results from a population‐based case‐crossover study
por: Grimnes, Gro, et al.
Publicado: (2017)

Impact of Venous Thromboembolism on the Formation and Progression of Carotid Atherosclerosis: The Tromsø Study
por: Lind, Caroline, et al.
Publicado: (2017)

The Role of Stroke as a Trigger for Incident Venous Thromboembolism: Results from a Population-based Case-Crossover Study
por: Morelli, Vânia M., et al.
Publicado: (2019)

The association between red cell distribution width and venous thromboembolism is not explained by myocardial infarction, stroke, or cancer
por: Ellingsen, Trygve S., et al.
Publicado: (2018)

Risk of a permanent work-related disability pension after incident venous thromboembolism in Denmark: A population-based cohort study
por: Jørgensen, Helle, et al.
Publicado: (2021)

Atrial fibrillation, venous thromboembolism, ischemic stroke, and all‐cause mortality: The Tromsø study
por: Hald, Erin Mathiesen, et al.
Publicado: (2020)

Venous Thromboembolism Increases the Risk of Atrial Fibrillation: The Tromsø Study
por: Hald, Erin M., et al.
Publicado: (2014)

C-reactive protein and risk of venous thromboembolism: results from a population-based case-crossover study
por: Grimnes, Gro, et al.
Publicado: (2018)

Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP)
por: Timp, Jasmijn F., et al.
Publicado: (2019)

Correction: Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP)
por: Timp, Jasmijn F., et al.
Publicado: (2021)

Estimated lifetime risk of venous thromboembolism in men and women in a Danish nationwide cohort: impact of competing risk of death
por: Arnesen, Carl Arne Løchen, et al.
Publicado: (2021)

Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study
por: Rinde, Ludvig B., et al.
Publicado: (2016)

Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromsø Study
por: Småbrekke, Birgit, et al.
Publicado: (2016)

Red Cell Distribution Width and Risk of Atrial Fibrillation and Subsequent Thromboembolism: The Tromsø Study
por: Hald, Erin M., et al.
Publicado: (2020)

Association between cardiovascular risk factors and venous thromboembolism in the elderly
por: Wang, Huijie, et al.
Publicado: (2022)

Joint effect of myocardial infarction and obesity on the risk of venous thromboembolism: The Tromsø Study
por: Sejrup, Joakim K., et al.
Publicado: (2022)

Effective filtering strategies to improve data quality from population-based whole exome sequencing studies
por: Carson, Andrew R, et al.
Publicado: (2014)

Fibrinogen Gamma Chain Mutations Provoke Fibrinogen and Apolipoprotein B Plasma Deficiency and Liver Storage
por: Callea, Francesco, et al.
Publicado: (2017)

Existing data sources in clinical epidemiology: the Scandinavian Thrombosis and Cancer Cohort
por: Jensvoll, Hilde, et al.
Publicado: (2015)

Risk and Risk Factors Associated With Recurrent Venous Thromboembolism Following Surgery in Patients With History of Venous Thromboembolism
por: Nemeth, Banne, et al.
Publicado: (2019)

Statin use and risk of recurrent venous thrombosis: results from the MEGA follow‐up study
por: Brækkan, Sigrid K., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2en8kio594jb2a14v8gk6neou1